NCT05655702 DRug Use & Infections in ViEtnam: TuBerculosis Control
| NCT ID | NCT05655702 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ANRS, Emerging Infectious Diseases |
| Condition | Tuberculosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2023-10-02 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 4,000 participants in total. It began in 2023-10-02 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The overarching purpose of the proposed research is to demonstrate that a targeted, multi-component community-based intervention among PWID in Hai Phong will decrease TB prevalence among this very high-risk population.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Self-declaring injecting heroin or any other drug * Positive urine test for heroin or methamphetamine * Presence of recent injection site marks Exclusion Criteria: * Unable to understand or refused to sign informed consent * Patients currently under treatment for active TB * Any condition which might, in the investigator's opinion, compromise the safety of the patient by participating in the study, including very severe clinical condition * Person deprived of freedom by a judicial or administrative decision
Contact & Investigator
Nicolas NAGOT
PRINCIPAL INVESTIGATOR
PCCI UMR 1058 - INSERM, Univ Montpellier, EFS, Montpellier, Franc
Frequently Asked Questions
Who can join the NCT05655702 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05655702 currently recruiting?
Yes, NCT05655702 is actively recruiting participants. Contact the research team at marion.bonneton@inserm.fr for enrollment information.
Where is the NCT05655702 trial being conducted?
This trial is being conducted at Haiphong, Vietnam, Haiphong, Vietnam.
Who is sponsoring the NCT05655702 clinical trial?
NCT05655702 is sponsored by ANRS, Emerging Infectious Diseases. The principal investigator is Nicolas NAGOT at PCCI UMR 1058 - INSERM, Univ Montpellier, EFS, Montpellier, Franc. The trial plans to enroll 4,000 participants.